Literature DB >> 26261662

Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings.

David A Shustik1, David Ce Ng2, Kesavan Sittampalam1.   

Abstract

Phosphaturic mesenchymal tumour mixed connective tissue variant (PMTMCT) is a rare tumour occurring in bone and soft tissue that usually behaves in a benign manner. Elaboration of biologically active substances by this tumour gives rise to a paraneoplastic syndrome known as oncogenic osteomalacia, manifesting clinically as bone pain, generalized weakness and pathological fractures. Recognition of PMTMCT and its associated syndrome is important, as resection of the tumour in most instances results in prompt resolution of symptoms. Previously reported cases of this tumour have emphasized the consistent presence of certain histological features that are considered prerequisite for making the diagnosis of PMTMCT. We describe three cases of PMTMCT, of which two first presented with progressive symptoms of osteomalacia and one remained clinically silent aside from the symptom of a palpable lump. Our cases highlight the wide-ranging histological patterns displayed by these tumours, and draw attention to certain microscopic findings that until now have been given little if any mention. Tentacular growth pattern and satellite nodules appear to be common findings in PMTMCTs, and can make complete surgical excision of these tumours challenging. The ability of this otherwise histologically benign tumour to permeate vascular spaces has to our knowledge never been described previously. One tumour lacked the characteristic calcifying matrix of PMTMCT, suggesting that in some tumours this defining feature may be focal if not entirely absent. PMTMCT shares features with and can resemble a variety of bone and soft tissue neoplasms, requiring the surgical pathologist to be familiar with this entity.

Entities:  

Keywords:  Phosphaturic mesenchymal tumour; matrix-producing tumours; oncogenic osteomalacia; phosphaturia; tumour induced osteomalacia

Mesh:

Substances:

Year:  2015        PMID: 26261662      PMCID: PMC4525996     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

1.  Use of immunohistochemistry for SSTR2A to support a diagnosis of phosphaturic mesenchymal tumour.

Authors:  Ellery Clugston; Anna C Gill; Nicole Graf; Fiona Bonar; Anthony J Gill
Journal:  Pathology       Date:  2015-02       Impact factor: 5.306

2.  Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.

Authors:  Yasuo Imanishi; Jun Hashimoto; Wataru Ando; Keisuke Kobayashi; Takafumi Ueda; Yuki Nagata; Akimitsu Miyauchi; Hajime M Koyano; Hiroshi Kaji; Takatoshi Saito; Koichi Oba; Yasato Komatsu; Tomoaki Morioka; Katsuhito Mori; Takami Miki; Masaaki Inaba
Journal:  J Bone Miner Metab       Date:  2011-07-08       Impact factor: 2.626

3.  A nonphosphaturic mesenchymal tumor mixed connective tissue variant of the sacrum.

Authors:  Andreas F Mavrogenis; Vasileios I Sakellariou; Konstantinos Soultanis; Helen Mahera; Demetrios S Korres; Panayiotis J Papagelopoulos
Journal:  Orthopedics       Date:  2010-11-02       Impact factor: 1.390

4.  Frequent expression of fibroblast growth factor-23 (FGF23) mRNA in aneurysmal bone cysts and chondromyxoid fibromas.

Authors:  Rondell Graham; Smita Krishnamurthy; Andre Oliveira; Carrie Inwards; Andrew L Folpe
Journal:  J Clin Pathol       Date:  2012-08-29       Impact factor: 3.411

5.  Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia.

Authors:  Clemens Bergwitz; Michael T Collins; Ravi S Kamath; Andrew E Rosenberg
Journal:  N Engl J Med       Date:  2011-10-27       Impact factor: 91.245

6.  RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.

Authors:  Armita Bahrami; Sharon W Weiss; Elizabeth Montgomery; Andrew E Horvai; Long Jin; Carrie Y Inwards; Andrew L Folpe
Journal:  Am J Surg Pathol       Date:  2009-09       Impact factor: 6.394

Review 7.  Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.

Authors:  Victoria L Woo; Regina Landesberg; Erik A Imel; Steven R Singer; Andrew L Folpe; Michael J Econs; Taeyun Kim; Lara R Harik; Thomas P Jacobs
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-10-14

8.  Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).

Authors:  Michelle Houang; Adele Clarkson; Loretta Sioson; Marianne S Elston; Roderick J Clifton-Bligh; Michael Dray; Dominique Ranchere-Vince; Anne-Valerie Decouvelaere; Arnaud de la Fouchardiere; Anthony J Gill
Journal:  Hum Pathol       Date:  2013-09-20       Impact factor: 3.466

Review 9.  Phosphaturic mesenchymal tumour of the sinonasal area: case report and review of the literature.

Authors:  Pavel Komínek; Ivo Stárek; Marie Geierová; Petr Matoušek; Karol Zeleník
Journal:  Head Neck Oncol       Date:  2011-03-16

Review 10.  Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.

Authors:  Fang-Ke Hu; Fang Yuan; Cheng-Ying Jiang; Da-Wei Lv; Bei-Bei Mao; Qiang Zhang; Zeng-Qiang Yuan; Yan Wang
Journal:  Chin J Cancer       Date:  2011-11
View more
  3 in total

1.  Phosphaturic Mesenchymal Tumor Masquerading as Mesenchymal Tumors with Diverse Differential Diagnosis: Series of 4 Cases with Emphasis on Histomorphological Spectrum.

Authors:  R T Rajeswarie; Akhila Lakshmikantha; S Kannan; V Pillai; K Prasad
Journal:  Indian J Surg Oncol       Date:  2021-04-28

2.  Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.

Authors:  Lulu Sun; Carina Dehner; Jason Kenney; Samantha M McNulty; Xiaopei Zhu; John D Pfeifer; Horacio M Maluf; John S A Chrisinger
Journal:  Virchows Arch       Date:  2020-11-05       Impact factor: 4.064

3.  Phosphaturic Mesenchymal Tumors from Head to Toe: Imaging Findings and Role of the Radiologist in Diagnosing Tumor-Induced Osteomalacia.

Authors:  Ameya S Kawthalkar; Amit K Janu; Mrunmayee S Deshpande; Kunal B Gala; Ashish Gulia; Ajay Puri
Journal:  Indian J Orthop       Date:  2020-01-13       Impact factor: 1.251

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.